We are live on ! Find out more
GT

Greenleaf Trust Portfolio holdings

AUM $10.4B
1-Year Est. Return 0.97%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+0.97%
3 Year Est. Return
+37.24%
5 Year Est. Return
+56.69%
10 Year Est. Return
+246.06%
AUM
$3.81B
AUM Growth
+$8.97M
Cap. Flow
-$86.1M
Cap. Flow %
-2.26%
Top 10 Hldgs %
85.83%
Holding
256
New
47
Increased
84
Reduced
80
Closed
12

Top Sells

Rank Stock Value
1
SYK icon
Stryker
SYK
+$130M
2
LLTC
Linear Technology Corp
LLTC
+$4.38M
3
GILD icon
Gilead Sciences
GILD
+$3.72M
4
PII icon
Polaris
PII
+$3.44M
5
AFL icon
Aflac
AFL
+$2.4M

Sector Composition

Rank Sector Weight
1 Healthcare 82.02%
2 Financials 2.52%
3 Technology 2.29%
4 Consumer Staples 1.51%
5 Communication Services 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMM icon
26
3M
MMM
$91.8B
$9.55M 0.25%
63,970
-3,791
-6% -$547K
CHKP icon
27
Check Point Software Technologies
CHKP
$14.3B
$9.09M 0.24%
107,586
-1,701
-2% -$140K
EEM icon
28
iShares MSCI Emerging Markets ETF
EEM
$27.5B
$9.07M 0.24%
259,021
+51,940
+25% +$1.87M
SYF icon
29
Synchrony
SYF
$24.4B
$8.7M 0.23%
+239,969
New +$7.66M
EFV icon
30
iShares MSCI EAFE Value ETF
EFV
$28.3B
$8.47M 0.22%
179,293
+150,295
+518% +$6.98M
GWPH
31
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$8.35M 0.22%
+74,686
New +$8.99M
SNI
32
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$8.24M 0.22%
115,451
-16,965
-13% -$1.15M
CL icon
33
Colgate-Palmolive
CL
$74.8B
$7.9M 0.21%
120,743
-15,294
-11% -$1.05M
ROP icon
34
Roper Technologies
ROP
$40.4B
$7.79M 0.2%
42,555
+335
+0.8% +$60.1K
MON
35
DELISTED
Monsanto Co
MON
$7.74M 0.2%
73,538
+240
+0.3% +$24.6K
V icon
36
Visa
V
$677B
$7.64M 0.2%
97,871
+1,601
+2% +$129K
C icon
37
Citigroup
C
$213B
$7.47M 0.2%
125,662
+119,399
+1,906% +$6.44M
EW icon
38
Edwards Lifesciences
EW
$49.4B
$7.07M 0.19%
226,269
+1,935
+0.9% +$62.7K
CTSH icon
39
Cognizant
CTSH
$25.2B
$7.04M 0.18%
125,708
-2,102
-2% -$112K
DHR icon
40
Danaher
DHR
$138B
$7.03M 0.18%
101,925
+1,171
+1% +$81.3K
HSY icon
41
Hershey
HSY
$37.3B
$6.45M 0.17%
62,340
-1,045
-2% -$103K
PYPL icon
42
PayPal
PYPL
$49.9B
$6.44M 0.17%
163,107
-6,875
-4% -$276K
AEP icon
43
American Electric Power
AEP
$70.4B
$6.41M 0.17%
101,875
+3,315
+3% +$204K
GILD icon
44
Gilead Sciences
GILD
$165B
$6.22M 0.16%
86,924
-50,018
-37% -$3.72M
IJJ icon
45
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.83B
$6.12M 0.16%
84,296
-2,330
-3% -$161K
PII icon
46
Polaris
PII
$3.83B
$6.05M 0.16%
73,425
-42,196
-36% -$3.44M
PFE icon
47
Pfizer
PFE
$143B
$5.94M 0.16%
192,769
-16,197
-8% -$494K
IJK icon
48
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.6B
$5.93M 0.16%
130,256
-4,680
-3% -$206K
CRM icon
49
Salesforce
CRM
$154B
$5.92M 0.16%
+86,460
New +$6.27M
JNJ icon
50
Johnson & Johnson
JNJ
$640B
$5.83M 0.15%
50,565
+1,734
+4% +$200K

Similar funds

Greenleaf Trust's Q4 2016 Portfolio in Review

As of Q4 2016, Greenleaf Trust held 256 positions worth $3.81B, up 0.24% from $3.8B the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Greenleaf Trust's Q4 2016 filing shows 47 new, 84 increased, 80 reduced and 12 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 74,686 shares worth $8.35M. The largest sale was Stryker, an estimated $130M.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, down from 83% a quarter earlier, followed by Financials and Technology.

  • Greenleaf Trust's largest Q4 2016 buy was GW Pharmaceuticals Plc American Depositary Shares: 74,686 shares worth $8.35M.
  • Greenleaf Trust added most to iShares Core S&P 500 ETF in Q4 2016, an estimated $15.9M increase.
  • Greenleaf Trust's biggest Q4 2016 reduction was Stryker, cutting an estimated $130M.
  • Greenleaf Trust fully exited Linear Technology Corp in Q4 2016, selling an estimated $4.38M.
  • Greenleaf Trust's ten largest holdings make up 86% of its $3.81B portfolio in Q4 2016.
  • Greenleaf Trust opened 47 new positions and closed 12 in Q4 2016.
  • Greenleaf Trust's portfolio value rose 0.24% quarter-over-quarter to $3.81B.

Based on Greenleaf Trust's 13F filing for Q4 2016, filed 24 Jan 2017.